The company will strengthen its position in the ‘green solvent’ market by increasing its capacity by 20% to 120,000 MTPA from 100,000 MTPA before the end of current fiscal
Addition of Pepscan with its peptide discovery, lead optimization and GMP manufacturing capabilities provides end-to-end offering to Biosynth Carbosynth’s peptide customers.
The company is now introducing the product into the India pharmaceutical market.
The acquisition is subject to customary closing conditions and necessary regulatory approvals. The financial terms of the transaction are confidential
To lay a technological foundation for developing exosome-based medicines and cosmetic products for dermatitis treatment
This partnership allows both companies to become first movers to bridge an inevitable gap with the largest organizations in the pharmaceutical, nutraceutical, cosmetic, and veterinary sectors
The minister exhorted the pharmaceutical sector to prepare a plan for the next 25 years
The joint partnership, powered by Cloudbyz Clinical Research Management Platform and ClinChoice's industry-leading transformation services, will provide an end-to-end clinical research management technology platform and services to customers
JEEN’s portfolio includes a diverse range of specialized active ingredients, botanical extracts, and complexes serving functional applications for skin and hair care
Subscribe To Our Newsletter & Stay Updated
